[go: up one dir, main page]

HUE059925T2 - Módosított aminoacil-tRNS-szintetáz és alkalmazása - Google Patents

Módosított aminoacil-tRNS-szintetáz és alkalmazása

Info

Publication number
HUE059925T2
HUE059925T2 HUE16764874A HUE16764874A HUE059925T2 HU E059925 T2 HUE059925 T2 HU E059925T2 HU E16764874 A HUE16764874 A HU E16764874A HU E16764874 A HUE16764874 A HU E16764874A HU E059925 T2 HUE059925 T2 HU E059925T2
Authority
HU
Hungary
Prior art keywords
application
trna synthetase
modified aminoacyl
aminoacyl
modified
Prior art date
Application number
HUE16764874A
Other languages
English (en)
Inventor
Atsushi Ohta
Yusuke Yamagishi
Atsushi Matsuo
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of HUE059925T2 publication Critical patent/HUE059925T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93Ligases (6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/30Nucleotides
    • C12P19/34Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
HUE16764874A 2015-03-13 2016-03-11 Módosított aminoacil-tRNS-szintetáz és alkalmazása HUE059925T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015051202 2015-03-13

Publications (1)

Publication Number Publication Date
HUE059925T2 true HUE059925T2 (hu) 2023-01-28

Family

ID=56918843

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE16764874A HUE059925T2 (hu) 2015-03-13 2016-03-11 Módosított aminoacil-tRNS-szintetáz és alkalmazása

Country Status (6)

Country Link
US (3) US10815489B2 (hu)
EP (2) EP4166664A1 (hu)
JP (3) JP7020910B2 (hu)
DK (1) DK3269809T3 (hu)
HU (1) HUE059925T2 (hu)
WO (1) WO2016148044A1 (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9409952B2 (en) 2011-12-28 2016-08-09 Chugai Seiyaku Kabushiki Kaisha Peptide-compound cyclization method
HUE059925T2 (hu) 2015-03-13 2023-01-28 Chugai Pharmaceutical Co Ltd Módosított aminoacil-tRNS-szintetáz és alkalmazása
WO2018143145A1 (ja) 2017-01-31 2018-08-09 中外製薬株式会社 無細胞翻訳系におけるペプチドの合成方法
JP7232758B2 (ja) 2017-06-09 2023-03-06 中外製薬株式会社 膜透過性の高い環状ペプチド化合物、及びこれを含むライブラリ
KR20250007021A (ko) 2017-06-09 2025-01-13 추가이 세이야쿠 가부시키가이샤 N-치환 아미노산을 포함하는 펩타이드의 합성 방법
US11492369B2 (en) 2017-12-15 2022-11-08 Chugai Seiyaku Kabushiki Kaisha Method for producing peptide, and method for processing bases
EP3775216A4 (en) * 2018-04-03 2022-04-13 The University of Queensland Oligonucleotide-mediated sense codon reassignment
JPWO2019235581A1 (ja) * 2018-06-06 2021-07-08 国立大学法人大阪大学 Regnase−1が関与する疾患の治療および/または予防方法
KR102841441B1 (ko) 2018-11-07 2025-07-31 추가이 세이야쿠 가부시키가이샤 O-치환 세린 유도체의 제조 방법
WO2020111238A1 (ja) 2018-11-30 2020-06-04 中外製薬株式会社 ペプチド化合物、またはアミド化合物の脱保護法および固相反応における脱樹脂方法、並びにペプチド化合物の製造方法
CN113454058B (zh) 2018-12-12 2024-03-22 中外制药株式会社 具有能形成分子内氢键的官能团的氨基酸、包含该氨基酸的肽化合物、及其制备方法
CN120518504A (zh) 2019-03-15 2025-08-22 中外制药株式会社 芳香族氨基酸衍生物的制备方法
JP2022545625A (ja) * 2019-08-08 2022-10-28 ブリックバイオ,インコーポレイテッド 非天然アミノ酸の部位特異的組込みのためのアミノアシルtrnaシンテターゼおよび細胞株
WO2021090855A1 (ja) 2019-11-07 2021-05-14 中外製薬株式会社 Kras阻害作用を有する環状ペプチド化合物
KR20220113729A (ko) 2019-12-12 2022-08-16 추가이 세이야쿠 가부시키가이샤 비천연 아미노산을 포함하는 펩타이드의 제조 방법
EP4257978A4 (en) 2020-12-25 2024-11-13 Chugai Seiyaku Kabushiki Kaisha METHOD FOR SCREENING CANDIDATE MOLECULES CAPABLE OF FORMING A COMPLEX IN CONJUNCTION WITH MULTIPLE TARGET MOLECULES
IL316253A (en) 2022-05-06 2025-01-01 Chugai Pharmaceutical Co Ltd A cyclic compound with selective KRAS inhibitory effect on HRAS and NRAS
EP4594333A2 (en) * 2022-09-28 2025-08-06 President and Fellows of Harvard College Evolution of fluorogenic sensors
JPWO2024128195A1 (hu) 2022-12-12 2024-06-20

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57159747A (en) 1981-03-27 1982-10-01 Kenji Okawa Synthesis of amino acid derivative
JPS60169451A (ja) 1984-02-13 1985-09-02 Mitsui Toatsu Chem Inc L−フエニルアラニンの分離精製法
FR2583432B1 (fr) 1985-06-13 1988-11-04 Inst Francais Du Petrole Procede de production enzymatique de l-a-aminoacides a partir d'a-cetoacides
ES8607214A1 (es) 1985-10-16 1986-06-01 Gema Sa Procedimiento enzimatico de resolucion de n-fenilacetil-ami-nocompuestos y purificacion de sus isomeros opticamente ac- tivos
US4859736A (en) 1987-03-30 1989-08-22 Ciba-Geigy Corporation Synthetic polystyrene resin and its use in solid phase peptide synthesis
DE3733198A1 (de) 1987-10-01 1989-04-13 Kernforschungsanlage Juelich Enzymatisches verfahren zur herstellung von dipeptiden
JPH0681759B2 (ja) 1988-03-31 1994-10-19 信越化学工業株式会社 ポリペプチドの製造方法
ATE332368T1 (de) 1997-01-21 2006-07-15 Gen Hospital Corp Selektion von proteinen mittels rns-protein fusionen
US20020068301A1 (en) 1997-05-28 2002-06-06 Hung-Sen Lai Cyclic peptide libraries and methods of use thereof to identify binding motifs
JP4502293B2 (ja) 1999-06-04 2010-07-14 長瀬産業株式会社 軸不斉を有する光学活性な4級アンモニウム塩、その製法およびα−アミノ酸誘導体の不斉合成への応用
DE19942624A1 (de) 1999-08-28 2001-03-08 Chemotopix Gmbh Verfahren zur Herstellung von zyklischen Peptidomimetika
US6914122B2 (en) 2000-04-19 2005-07-05 Schering Corporation Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties
HK1049331A1 (en) 2000-04-21 2003-05-09 Nagase & Co., Ltd. Optically active quaternary ammonium salt with axial asymmetry, its preparation method, and application of asymmetric synthesis of α amino acid derivatives
CA2444098C (en) 2001-04-19 2016-06-21 The Scripps Research Institute Methods and composition for the production of orthogonal trna-aminoacyltrna synthetase pairs
EP1424395B1 (en) 2001-08-01 2011-07-27 Japan Science and Technology Agency Tyrosyl-trna synthase variants
US7288372B2 (en) 2002-01-17 2007-10-30 Ambergen, Inc. Methods for the preparation of chemically misaminoacylated tRNA via protective groups
WO2003089454A2 (en) 2002-04-19 2003-10-30 California Institute Of Technology Unnatural amino acid containing display libraries
JP4490663B2 (ja) 2003-09-22 2010-06-30 株式会社東京大学Tlo イソロイシンtRNA(tRNAIle)のライシジン合成酵素(TilS)としてのmesJ遺伝子産物及びその相同性遺伝子(COG0037)
ES2295961T3 (es) 2003-12-31 2008-04-16 F. Hoffmann-La Roche Ag Proceso para la sintesis peptidica utilizacndo una cantidad reducida de agente de desproteccion.
EP1725250A2 (en) 2004-02-18 2006-11-29 Frutarom Ltd. Method for the preparation of peptide-oligonucleotide conjugates
WO2007066627A1 (ja) 2005-12-06 2007-06-14 The University Of Tokyo 多目的アシル化触媒とその用途
SI1999259T1 (sl) 2006-03-03 2014-11-28 California Institute Of Technology Usmerjeno vključevanje amino kislin v molekule
JP5119437B2 (ja) 2006-03-06 2013-01-16 国立大学法人東京工業大学 機能性非天然型タンパク質の製造法、及び当該タンパク質の部位特異的修飾・固定化法
CA2649303C (en) 2006-04-11 2016-09-27 Sloan-Kettering Institute For Cancer Research Homogeneous erythropoietin and other peptides and proteins, methods and intermediates for their preparation
JP2007319064A (ja) 2006-05-31 2007-12-13 Japan Science & Technology Agency 修飾化アミノ酸を部位特異的に導入したタンパク質を発現させる方法
JP5200241B2 (ja) 2006-11-17 2013-06-05 国立大学法人 東京大学 N末端に非天然骨格をもつポリペプチドの翻訳合成とその応用
US8227209B2 (en) 2007-03-06 2012-07-24 Tokyo Institute Of Technology Process for producing functional non-naturally occurring proteins, and method for site-specific modification and immobilization of the proteins
EP2141175B1 (en) 2007-03-26 2016-07-27 The University of Tokyo Process for synthesizing cyclic peptide compound
CA2706889C (en) 2007-09-20 2018-08-28 Riken Mutant pyrrolysyl-trna synthetase, and method for production of protein having non-natural amino acid integrated therein by using the same
JP2009096791A (ja) 2007-09-26 2009-05-07 Kaneka Corp アミノ酸の製造方法
EP2177533A1 (en) 2008-10-09 2010-04-21 TU München Multiple N-methylated cyclic hexapeptides for treatment of neurogenic inflammation
TWI468375B (zh) 2008-10-27 2015-01-11 Janssen Pharmaceutica Nv 製備經保護之l-丙胺酸衍生物之方法
WO2010053050A1 (ja) 2008-11-04 2010-05-14 株式会社カネカ O-アルキルセリンおよびn-ベンジル-o-アルキルセリンの製造法
JP2012510486A (ja) 2008-12-03 2012-05-10 エフ.ホフマン−ラ ロシュ アーゲー 治療用ペプチドの製造方法
CA2759468A1 (en) 2009-05-01 2010-11-04 F. Hoffmann-La Roche Ag Insulinotropic peptide synthesis using solid and solution phase combination techniques
US20120208720A1 (en) 2009-10-22 2012-08-16 Kenji Kashiwagi Rapid display method in translational synthesis of peptide
GB0919194D0 (en) 2009-11-02 2009-12-16 Lytix Biopharma As Compounds
US20110118314A1 (en) 2009-11-16 2011-05-19 Weiya Yun Piperidine analogs as glycogen synthase activators
JP2011139667A (ja) 2010-01-07 2011-07-21 Tottori Univ プロリンおよびβ−アラニンをN末端に有するジペプチド、及びその環化ジペプチドの酵素合成法
EP2380596A1 (en) 2010-04-20 2011-10-26 Technische Universität München Cyclopentapeptide derivatives and uses thereof
JP5725467B2 (ja) 2010-08-27 2015-05-27 国立大学法人 東京大学 新規人工翻訳合成系
JP5818237B2 (ja) 2010-09-09 2015-11-18 国立大学法人 東京大学 N−メチルアミノ酸およびその他の特殊アミノ酸を含む特殊ペプチド化合物ライブラリーの翻訳構築と活性種探索法
JP6206943B2 (ja) 2010-12-03 2017-10-04 国立大学法人 東京大学 ペプチドライブラリーの製造方法、ペプチドライブラリー、及びスクリーニング方法
WO2012122059A1 (en) 2011-03-04 2012-09-13 New York University Hydrogen bond surrogate macrocycles as modulators of ras
US9133245B2 (en) 2011-06-13 2015-09-15 Trustees Of Boston College Cyclic lactadherin peptide mimetics and their uses
WO2013009868A1 (en) 2011-07-11 2013-01-17 Yale University Compositions and methods for making selenocysteine containing polypeptides
US9409952B2 (en) 2011-12-28 2016-08-09 Chugai Seiyaku Kabushiki Kaisha Peptide-compound cyclization method
GB201215538D0 (en) 2012-08-31 2012-10-17 Stetsenko Dmitry Method and compositions for removing acid-labile protecting groups
JP6440055B2 (ja) 2013-05-10 2018-12-19 国立大学法人 東京大学 ペプチドライブラリの製造方法、ペプチドライブラリ、及びスクリーニング方法
CN105980350B (zh) 2013-08-05 2018-11-27 米迪缪尼有限公司 氨基酸衍生物
WO2015019999A1 (ja) 2013-08-05 2015-02-12 国立大学法人東京大学 荷電性非タンパク質性アミノ酸含有ペプチドの製造方法
US20170022254A1 (en) 2014-04-08 2017-01-26 Novartis Ag Novel Aldehyde Acetal Based Processes for the Manufacture of Macrocyclic Depsipeptides and New Intermediates
US20170112896A1 (en) 2014-05-20 2017-04-27 Ohio State Innovation Foundation Small molecule rac or rho inhibitors
EP3152226B1 (en) 2014-06-06 2019-05-29 Technische Universität München Modified cyclopentapeptides and uses thereof
US20170369871A1 (en) 2015-01-12 2017-12-28 Synthorx, Inc. Incorporation of unnatural nucleotides and methods thereof
HUE059925T2 (hu) 2015-03-13 2023-01-28 Chugai Pharmaceutical Co Ltd Módosított aminoacil-tRNS-szintetáz és alkalmazása
EP3274459A4 (en) 2015-03-27 2018-08-22 The University of Queensland Platform for non-natural amino acid incorporation into proteins
JP2017043615A (ja) 2015-08-27 2017-03-02 塩野義製薬株式会社 環状ペプチドの膜透過性および/または代謝安定性を改善するシクロプロパンアミノ酸ユニット
US9913245B2 (en) 2015-10-23 2018-03-06 Qualcomm Incorporated Multi-subscriber identity module (SIM) call setup
AU2017214550B2 (en) 2016-02-04 2024-03-07 The Johns Hopkins University Synthesis and composition of Rapafucin libraries
WO2017150732A1 (ja) 2016-03-03 2017-09-08 中外製薬株式会社 チオール基をアミノ基近傍に有するアミノ酸をn末端に持つ非環状ペプチド-核酸複合体、そのライブラリー、およびそれから誘導される環状ペプチド-核酸複合体ライブラリーの製造方法
US10954287B2 (en) 2016-04-15 2021-03-23 Ra Pharmaceuticals, Inc. Ras binding peptides and methods of use
IT201600122363A1 (it) 2016-12-02 2018-06-02 Dolores Fregona Composti di coordinazione, sintesi, nanoformulazione ed uso degli stessi in oncologia
WO2018143145A1 (ja) 2017-01-31 2018-08-09 中外製薬株式会社 無細胞翻訳系におけるペプチドの合成方法
JP7232758B2 (ja) 2017-06-09 2023-03-06 中外製薬株式会社 膜透過性の高い環状ペプチド化合物、及びこれを含むライブラリ
KR20250007021A (ko) 2017-06-09 2025-01-13 추가이 세이야쿠 가부시키가이샤 N-치환 아미노산을 포함하는 펩타이드의 합성 방법
US11492369B2 (en) 2017-12-15 2022-11-08 Chugai Seiyaku Kabushiki Kaisha Method for producing peptide, and method for processing bases
KR102841441B1 (ko) 2018-11-07 2025-07-31 추가이 세이야쿠 가부시키가이샤 O-치환 세린 유도체의 제조 방법
WO2020111238A1 (ja) 2018-11-30 2020-06-04 中外製薬株式会社 ペプチド化合物、またはアミド化合物の脱保護法および固相反応における脱樹脂方法、並びにペプチド化合物の製造方法
CN113454058B (zh) 2018-12-12 2024-03-22 中外制药株式会社 具有能形成分子内氢键的官能团的氨基酸、包含该氨基酸的肽化合物、及其制备方法
CN119080856A (zh) 2018-12-26 2024-12-06 中外制药株式会社 用于密码子扩展的突变tRNA
CN120518504A (zh) 2019-03-15 2025-08-22 中外制药株式会社 芳香族氨基酸衍生物的制备方法
WO2021090855A1 (ja) 2019-11-07 2021-05-14 中外製薬株式会社 Kras阻害作用を有する環状ペプチド化合物
KR20220113729A (ko) 2019-12-12 2022-08-16 추가이 세이야쿠 가부시키가이샤 비천연 아미노산을 포함하는 펩타이드의 제조 방법
KR20220121831A (ko) 2019-12-26 2022-09-01 추가이 세이야쿠 가부시키가이샤 번역용 조성물 및 펩타이드의 제조 방법
CN115667539A (zh) 2020-06-25 2023-01-31 中外制药株式会社 具有改变的遗传密码表的翻译系统
CN117279933A (zh) 2021-05-07 2023-12-22 中外制药株式会社 相对于hras和nras具有选择性kras抑制作用的环状化合物

Also Published As

Publication number Publication date
US20180127761A1 (en) 2018-05-10
US20210087572A1 (en) 2021-03-25
EP3269809A1 (en) 2018-01-17
EP3269809A4 (en) 2018-12-05
JP7292442B2 (ja) 2023-06-16
JP2022061999A (ja) 2022-04-19
US10815489B2 (en) 2020-10-27
JP2023116605A (ja) 2023-08-22
WO2016148044A1 (ja) 2016-09-22
JP7020910B2 (ja) 2022-02-16
US12163134B2 (en) 2024-12-10
US20250051784A1 (en) 2025-02-13
EP4166664A1 (en) 2023-04-19
DK3269809T3 (da) 2022-09-12
EP3269809B1 (en) 2022-07-27
JPWO2016148044A1 (ja) 2017-12-28
JP7661399B2 (ja) 2025-04-14

Similar Documents

Publication Publication Date Title
HUE059925T2 (hu) Módosított aminoacil-tRNS-szintetáz és alkalmazása
IL293377A (en) Hsd17b13 variants and uses thereof
HUE054159T2 (hu) HPK1 gátlók és azok alkalmazási módja
HUE057559T2 (hu) PD-1 elleni antitestek és alkalmazásaik
HUE046621T2 (hu) Promóter szekvencia és alkalmazásai
HUE067016T2 (hu) Önfeláldozó csoportokat tartalmazó konjugátumok és ezekkel kapcsolos eljárások
HUE045307T2 (hu) EGFRVIII-ellenes antitestek és alkalmazásaik
HUE047255T2 (hu) Syntac polipeptidek és alkalmazásaik
HUE064791T2 (hu) APRIL ellenes antitest molekulák és alkalmazásaik
HUE059788T2 (hu) PD-1 elleni antitestek és készítmények
HUE055473T2 (hu) Difluormetil-aminopiridinek és difluormetil-aminopirimidinek
HUE045216T2 (hu) Anti-CD79B antitestek és alkalmazási eljárások
HUE056596T2 (hu) Módosított biológiai szabályozó szer és ennek alkalmazásai
DK3452463T3 (da) Amidsubstituerede pyridinyltriazolderivater og anvendelser deraf
HUE048791T2 (hu) CD123 kötõszerek és alkalmazásaik
HUE054339T2 (hu) CD73-ra specifikus kötõmolekulák és alkalmazásaik
PL3265448T3 (pl) Proleki riluzolu i ich zastosowanie
PL3280441T3 (pl) Przeciwciała przeciwko sortilinie i sposoby ich stosowania
EP3334706A4 (en) PILLARARES AND USES THEREOF
HUE036281T2 (hu) Önbeálló fecskendõ és fecskendõcsatlakozás
HUE052771T2 (hu) C10orf54 elleni antitestek és alkalmazásuk
HUE059338T2 (hu) Ellenanyagok, alkalmazások és eljárások
DK3209773T3 (da) Prolintolerante tripeptidylpeptidaser og anvendelser deraf
HUE046509T2 (hu) Új vegyület és eljárás
DK3161139T3 (da) Tlr-4-specifikke aptamerer og anvendelser heraf